The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Hanover Media Strategy Limited naming Martin Conway .

Filed returns
20
match these filters
Matching filed returns per period 0 1 2 3 5 May–Aug 2020: 2 filed returns Sep–Dec 2020: 2 filed returns Jan–Apr 2021: 2 filed returns Jan–Apr 2022: 1 filed returns Sep–Dec 2022: 1 filed returns Jan–Apr 2023: 3 filed returns May–Aug 2023: 3 filed returns Sep–Dec 2023: 1 filed returns Jan–Apr 2024: 1 filed returns Sep–Dec 2024: 1 filed returns Sep–Dec 2025: 2 filed returns May–Aug 2026: 1 filed returns 2021 2022 2023 2024
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 Hanover Media Strategy Limited Transport Coalition briefing in the AV Room, Leinster House on 20 May 2026 concerning taxi supply and availability, including rural shortages, barriers to entry, passenger accessibility and reliability, and the night-time economy. (Public policy or programme) 15 On lobbying.ie
Sep–Dec 2025 Hanover Media Strategy Limited Health AV Room Briefing Event to discuss a Proposal for an Early Access Programme for Innovative Oncology Medicines (Public policy or programme) 41 On lobbying.ie
Sep–Dec 2025 Hanover Media Strategy Limited Transport Greening Corporate Fleets (Public policy or programme) 7 On lobbying.ie
Sep–Dec 2024 Hanover Media Strategy Limited Health Invite to Leinster House briefing on the burden of influenza in Ireland (Public policy or programme) 15 On lobbying.ie
Jan–Apr 2024 Hanover Media Strategy Limited Health Invitation to a roundtable discussion on the challenges and pressures posed by influenza on the Irish health system, with a particular focus on the over 65s population. (Public policy or programme) 15 On lobbying.ie
Sep–Dec 2023 Hanover Media Strategy Limited Health Chronic kidney disease in Ireland: recommendations to improve health outcomes for chronic kidney disease patients and reduce healthcare costs. (Matters involving public funds) 15 On lobbying.ie
May–Aug 2023 Hanover Media Strategy Limited Health Discussion on the level of influenza vaccine protection for the over 65 population in Ireland. (Public policy or programme) 23 On lobbying.ie
May–Aug 2023 Hanover Media Strategy Limited Health Ireland's readiness for the rollout of radioligand therapy (Public policy or programme) 10 On lobbying.ie
May–Aug 2023 Hanover Media Strategy Limited Health Rare Disease Policy (Legislation) 3 On lobbying.ie
Jan–Apr 2023 Hanover Media Strategy Limited Health The landscape for innovative and precision medicines in Ireland. (Public policy or programme) 12 On lobbying.ie
Jan–Apr 2023 Hanover Media Strategy Limited Health Ireland's readiness for the rollout of radioligand therapy (Public policy or programme) 12 On lobbying.ie
Jan–Apr 2023 Hanover Media Strategy Limited Health Rare Disease Policy (Legislation) 17 On lobbying.ie
Sep–Dec 2022 Hanover Media Strategy Limited Health Request for a meeting to discuss the landscape for innovative and precision medicines in Ireland. (Public policy or programme) 18 On lobbying.ie
Jan–Apr 2022 Hanover Media Strategy Limited Health Update on AstraZeneca sponsored roundtable outcomes held for Chronic Obstructive Pulmonary Disease (Public policy or programme) 14 On lobbying.ie
Jan–Apr 2021 Hanover Media Strategy Limited Health Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) 15 On lobbying.ie
Jan–Apr 2021 Hanover Media Strategy Limited Health Creation of national policy with regard to Orphan Medicinal Products (Legislation) 9 On lobbying.ie
Sep–Dec 2020 Hanover Media Strategy Limited Health Provided update to select politicians on developments in Oncology therapies and barriers to access (Matters involving public funds) 4 On lobbying.ie
Sep–Dec 2020 Hanover Media Strategy Limited Health Briefed select parliamentarians on potential Covid-19 vaccine (Public policy or programme) 22 On lobbying.ie
May–Aug 2020 Hanover Media Strategy Limited Health Update on potential COVID-19 Vaccine (Matters involving public funds) 4 On lobbying.ie
May–Aug 2020 Hanover Media Strategy Limited Health Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) 16 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 18 90.0%
Transport 2 10.0%